Pivotal Bioequivalence Study of Exemestane 25 mg Tablets Under Fasting Conditions in Healthy Subjects

NCT01760980 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Development halted by management

Conditions

Healthy

Interventions

DRUG: Reference product (A) Aromasin (Exemestane)
DRUG: Test product (B) Exemestane

Sponsor

Actavis Inc.